nach oben

Clinical Reviews in Allergy & Immunology

Erschienen in:

01.08.2011

Current Concepts on the Pathogenesis and Natural History of Steroid-Induced Osteonecrosis

verfasst von: Christian Powell, Christopher Chang, M. Eric Gershwin

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

The pathophysiology of non-traumatic osteonecrosis is more complex than that of traumatic osteonecrosis, and corticosteroid-induced osteonecrosis presents the greatest challenge because of the multiple effects of corticosteroids on multi-system pathways; these pathways include the effects of corticosteroids on osteoblast differentiation, osteoblast and osteoclast apoptosis, lipid metabolism, coagulation pathways, and calcium metabolism. These pathways are frequently interrelated with each other, which makes the pathogenesis even more difficult to understand. Host factors and underlying disease have been shown to play a significant role in the risk of developing osteonecrosis, and our understanding of the pathogenesis must be able to explain why some patients are at greater risk than others. Identification of genetic variants that convey additional risk will also help to personalize the way we deliver care, both in the prevention and treatment of osteonecrosis. Further understanding of the intricate immunologic and genetic pathways contributing to osteonecrosis is at the forefront of research and may soon lead to viable and less invasive non-surgical therapeutic strategies.

Powell C, Chang C, Naguwa SM, Cheema G, Gershwin ME (2010) Steroid induced osteonecrosis: an analysis of steroid dosing risk. Autoimmun Rev 9:721–743PubMedCrossRef

Chang C, Greenspan A, Gershwin ME. Osteonecrosis. In Firestein GS, Budd RC, Harris ED, McInnes IB, Ruddy S, Sergent JS (2009) Textbook of Rheumatology, 8th Edition, Saunders, Philadelphia, pp 1611–1628

Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME (2002) Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 32:94–124PubMed

Spencer JD, Brookes M (1988) Avascular necrosis and the blood supply of the femoral head. Clin Orthop Relat Res 235:127–140PubMed

Jacobs B (1978) Epidemiology of traumatic and nontraumatic osteonecrosis. Clin Orthop Relat Res 130:51–67PubMed

Atsumi T, Kuroki Y (1992) Role of impairment of blood supply of the femoral head in the pathogenesis of idiopathic osteonecrosis. Clin Orthop Relat Res 277:22–30PubMed

Jones LC, Mont MA, Le TB, Petri M, Hungerford DS, Wang P, Glueck CJ (2003) Procoagulants and osteonecrosis. J Rheumatol 30:783–791PubMed

Jones JP Jr (1999) Coagulopathies and osteonecrosis. Acta Orthop Belg 65(Suppl 1):5–8PubMed

Chandler FA (1948) Coronary disease of the hip. J Int Coll Surg 11:34–36PubMed

10.

Chandler FA (1949) Coronary disease of the hip. Clin Orthop Relat Res 2001:7–10

11.

Silvestrini G, Mocetti P, Ballanti P, Di Grezia R, Bonucci E (1999) Cytochemical demonstration of the glucocorticoid receptor in skeletal cells of the rat. Endocr Res 25:117–128PubMed

12.

Dempster DW, Moonga BS, Stein LS, Horbert WR, Antakly T (1997) Glucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis. J Endocrinol 154:397–406PubMedCrossRef

13.

Liesegang P, Romalo G, Sudmann M, Wolf L, Schweikert HU (1994) Human osteoblast-like cells contain specific, saturable, high-affinity glucocorticoid, androgen, estrogen, and 1 alpha, 25-dihydroxycholecalciferol receptors. J Androl 15:194–199PubMed

14.

Yoshioka T, Sato B, Matsumoto K, Ono K (1980) Steroid receptors in osteoblasts. Clin Orthop Relat Res 148:297–303PubMed

15.

Kerachian MA, Seguin C, Harvey EJ (2009) Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol 114:121–128PubMedCrossRef

16.

Calder JD, Buttery L, Revell PA, Pearse M, Polak JM (2004) Apoptosis—a significant cause of bone cell death in osteonecrosis of the femoral head. J Bone Joint Surg Br 86:1209–1213PubMedCrossRef

17.

Weinstein RS, Nicholas RW, Manolagas SC (2000) Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab 85:2907–2912PubMedCrossRef

18.

Kogianni G, Mann V, Ebetino F, Nuttall M, Nijweide P, Simpson H, Noble B (2004) Fas/CD95 is associated with glucocorticoid-induced osteocyte apoptosis. Life Sci 75:2879–2895PubMedCrossRef

19.

Weinstein RS, Chen JR, Powers CC, Stewart SA, Landes RD, Bellido T, Jilka RL et al (2002) Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest 109:1041–1048PubMed

20.

Kawai K, Tamaki A, Hirohata K (1985) Steroid-induced accumulation of lipid in the osteocytes of the rabbit femoral head. A histochemical and electron microscopic study. J Bone Joint Surg Am 67:755–763PubMed

21.

Boskey AL, Raggio CL, Bullough PG, Kinnett JG (1983) Changes in the bone tissue lipids in persons with steroid- and alcohol-induced osteonecrosis. Clin Orthop Relat Res 172:289–295PubMed

22.

Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102:274–282PubMedCrossRef

23.

Wang GJ, Cui Q, Balian G (2000) The Nicolas Andry award. The pathogenesis and prevention of steroid-induced osteonecrosis Clin Orthop Relat Res 370:295–310

24.

Aspenberg P (2006) Osteonecrosis of the jaw: what do bisphosphonates do? Expert Opin Drug Saf 5:743–745PubMedCrossRef

25.

Assael LA (2009) Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies. J Oral Maxillofac Surg 67:35–43PubMedCrossRef

26.

Bilezikian JP (2006) Osteonecrosis of the jaw—do bisphosphonates pose a risk? N Engl J Med 355:2278–2281PubMedCrossRef

27.

Pendrys DG, Silverman SL (2008) Osteonecrosis of the jaws and bisphosphonates. Curr Osteoporos Rep 6:31–38PubMedCrossRef

28.

Walter C, Pabst A, Ziebart T, Klein M, Al-Nawas B. Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro. Oral Dis 2010 (In press)

29.

Harper RN, Moore MA, Marr MC, Watts LE, Hutchins PM (1978) Arteriolar rarefaction in the conjunctiva of human essential hypertensives. Microvasc Res 16:369–372PubMedCrossRef

30.

Kerachian MA, Harvey EJ, Cournoyer D, Chow TY, Seguin C (2006) Avascular necrosis of the femoral head: vascular hypotheses. Endothelium 13:237–244PubMedCrossRef

31.

Feng Y, Yang SH, Xiao BJ, et al (2010) Decreased in the number and function of circulation endothelial progenitor cells in patients with avascular necrosis of the femoral head. Bone 46:32–40

32.

Li YM, Wang SX, Gao HS, Wang JG, Wei CS, Chen LM, Hui WL et al (2004) Factors of avascular necrosis of femoral head and osteoporosis in SARS patients' convalescence. Zhonghua Yi Xue Za Zhi 84:1348–1353PubMed

33.

Jones JP Jr, Ramirez S, Doty SB (1993) The pathophysiologic role of fat in dysbaric osteonecrosis. Clin Orthop Relat Res 296:256–264PubMed

34.

Gray E, Thomas S, Mistry Y, Poole S (1996) Inhibition of tissue factor and cytokine release. Haemostasis 26(Suppl 1):92–95PubMed

35.

van Giezen JJ, Jansen JW (1992) Correlation of in vitro and in vivo decreased fibrinolytic activity caused by dexamethasone. Ann NY Acad Sci 667:199–201PubMedCrossRef

36.

Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C (2004) Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 141:47–56PubMed

37.

Boss JH, Misselevich I (2003) Osteonecrosis of the femoral head of laboratory animals: the lessons learned from a comparative study of osteonecrosis in man and experimental animals. Vet Pathol 40:345–354PubMedCrossRef

38.

Hirata T, Fujioka M, Takahashi KA, Asano T, Ishida M, Akioka K, Okamoto M et al (2007) Low molecular weight phenotype of Apo(a) is a risk factor of corticosteroid-induced osteonecrosis of the femoral head after renal transplant. J Rheumatol 34:516–522PubMed

39.

Ferrari P, Schroeder V, Anderson S, Kocovic L, Vogt B, Schiesser D, Marti HP et al (2002) Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients. Transplantation 74:1147–1152PubMedCrossRef

40.

Kang P, Shen B, Yang J, Pei F (2008) Circulating platelet-derived microparticles and endothelium-derived microparticles may be a potential cause of microthrombosis in patients with osteonecrosis of the femoral head. Thromb Res 123:367–373PubMedCrossRef

41.

Chotanaphuti T, Heebthamai D, Chuwong M, Kanchanaroek K (2009) The prevalence of thrombophilia in idiopathic osteonecrosis of the hip. J Med Assoc Thai 92(Suppl 6):S141–S146PubMed

42.

Glueck CJ, Freiberg RA, Boppana S, Wang P (2008) Thrombophilia, hypofibrinolysis, the eNOS T-786 C polymorphism, and multifocal osteonecrosis. J Bone Joint Surg Am 90:2220–2229PubMedCrossRef

43.

Glueck CJ, Freiberg RA, Wang P (2008) Heritable thrombophilia–hypofibrinolysis and osteonecrosis of the femoral head. Clin Orthop Relat Res 466:1034–1040PubMedCrossRef

44.

Seguin C, Kassis J, Busque L, Bestawros A, Theodoropoulos J, Alonso ML, Harvey EJ (2008) Non-traumatic necrosis of bone (osteonecrosis) is associated with endothelial cell activation but not thrombophilia. Rheumatology (Oxford) 47:1151–1155CrossRef

45.

Arlet J, Ficat P, Lartigue G, Tran MA (1972) Clinical research on intraosseous pressure in the upper femoral metaphysis and epiphysis in humans. Application to the diagnosis of ischemia and necrosis. Rev Rhum Mal Osteo-artic 39:717–723

46.

Wang KZ, Mao LZ, Hu CG (1994) Experimental study on mechanism of steroid-induced avascular necrosis of femoral head. Zhonghua Wai Ke Za Zhi 32:515–517PubMed

47.

Wang KZ, Wang CS, Wu YG, Chen H (2006) Changes of vessel in steroid-induced osteonecrosis of femoral head: experimental study of rabbits. Zhonghua Yi Xue Za Zhi 86:2024–2027PubMed

48.

Wang ZX, Yang ZX (1985) Experimental observations on the biological features and pathogenicity of Thelazia callipaeda parasitized in rabbits. Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 3:128–130PubMed

49.

Welch RD, Johnston CE 2nd, Waldron MJ, Poteet B (1993) Bone changes associated with intraosseous hypertension in the caprine tibia. J Bone Joint Surg Am 75:53–60PubMed

50.

Saito S, Ohzono K, Ono K (1992) Early arteriopathy and postulated pathogenesis of osteonecrosis of the femoral head. The intracapital arterioles Clin Orthop Relat Res 277:98–110

51.

Yang C, Yang S, Du J, Li J, Xu W, Xiong Y (2003) Experimental study of vascular endothelial growth factor gene therapy for avascular necrosis of the femoral head. J Huazhong Univ Sci Technolog Med Sci 23(297–299):316

52.

Li X, Jin L, Cui Q, Wang GJ, Balian G (2005) Steroid effects on osteogenesis through mesenchymal cell gene expression. Osteoporos Int 16:101–108PubMedCrossRef

53.

Harada I (1992) The effects of glucocorticoids on angiogenesis in vitro. Nippon Seikeigeka Gakkai Zasshi 66:763–770PubMed

54.

Wolff JE, Guerin C, Laterra J, Bressler J, Indurti RR, Brem H, Goldstein GW (1993) Dexamethasone reduces vascular density and plasminogen activator activity in 9 L rat brain tumors. Brain Res 604:79–85PubMedCrossRef

55.

Boss JH (2004) Experimental models of osteonecrosis of the femoral head. J Orthop Sci 9:533–534PubMedCrossRef

56.

Ichiseki T, Matsumoto T, Nishino M, Kaneuji A, Katsuda S (2004) Oxidative stress and vascular permeability in steroid-induced osteonecrosis model. J Orthop Sci 9:509–515PubMedCrossRef

57.

Ichiseki T, Kaneuji A, Katsuda S, Ueda Y, Sugimori T, Matsumoto T (2005) DNA oxidation injury in bone early after steroid administration is involved in the pathogenesis of steroid-induced osteonecrosis. Rheumatology (Oxford) 44:456–460CrossRef

58.

Ichiseki T, Matsumoto T (2006) Oxidative stress may underlie the sex differences seen in steroid-induced osteonecrosis models. Med Hypotheses 66:1256PubMedCrossRef

59.

Jaffe WL, Epstein M, Heyman N, Mankin HJ (1972) The effect of cortisone on femoral and humeral heads in rabbits. An experimental study. Clin Orthop Relat Res 82:221–228PubMedCrossRef

60.

Zhou Q, Li Q, Yang L, Liu F (2000) Changes of blood vessels in glucocorticoid-induced avascular necrosis of femoral head in rabbits. Zhonghua Wai Ke Za Zhi 38(212–215):213

61.

Chen XC, Weng J, Chen XQ, Du JZ, Zhu MP, Pan YQ, Liu M (2008) Relationships among magnetic resonance imaging, histological findings, and IGF-I in steroid-induced osteonecrosis of the femoral head in rabbits. J Zhejiang Univ Sci B 9:739–746PubMedCrossRef

62.

Cui Q, Wang GJ, Su CC, Balian G (1997) The Otto Aufranc Award. Lovastatin prevents steroid induced adipogenesis and osteonecrosis Clin Orthop Relat Res 344:8–19

63.

Wang GJ, Moga DB, Richemer WG, Sweet DE, Reger SI, Thompson RC (1978) Cortisone induced bone changes and its response to lipid clearing agents. Clin Orthop Relat Res 130:81–85PubMed

64.

Jones JP Jr (1985) Fat embolism and osteonecrosis. Orthop Clin North Am 16:595–633PubMed

65.

Motomura G, Yamamoto T, Irisa T, Miyanishi K, Nishida K, Iwamoto Y (2008) Dose effects of corticosteroids on the development of osteonecrosis in rabbits. J Rheumatol 35:2395–2399PubMedCrossRef

66.

Motomura G, Yamamoto T, Miyanishi K, Jingushi S, Iwamoto Y (2004) Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Arthritis Rheum 50:3387–3391PubMedCrossRef

67.

Yamamoto T, Irisa T, Sugioka Y, Sueishi K (1997) Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum 40:2055–2064PubMedCrossRef

68.

Motomura G, Yamamoto T, Miyanishi K, Kondo K, Hirota Y, Iwamoto Y (2008) Risk factors for developing osteonecrosis after prophylaxis in steroid-treated rabbits. J Rheumatol 35:2391–2394PubMedCrossRef

69.

Tokuhara Y, Wakitani S, Oda Y, Kaneshiro Y, Masada T, Kim M, Kadoya Y et al (2009) Low levels of steroid-metabolizing hepatic enzyme (cytochrome P450 3A) activity may elevate responsiveness to steroids and may increase risk of steroid-induced osteonecrosis even with low glucocorticoid dose. J Orthop Sci 14:794–800PubMedCrossRef

70.

Masada T, Iwakiri K, Oda Y, Kaneshiro Y, Iwaki H, Ohashi H, Takaoka K (2008) Increased hepatic cytochrome P4503A activity decreases the risk of developing steroid-induced osteonecrosis in a rabbit model. J Orthop Res 26:91–95PubMedCrossRef

71.

Kaneshiro Y, Oda Y, Iwakiri K, Masada T, Iwaki H, Hirota Y, Kondo K et al (2006) Low hepatic cytochrome P450 3A activity is a risk for corticosteroid-induced osteonecrosis. Clin Pharmacol Ther 80:396–402PubMedCrossRef

72.

Asano T, Takahashi KA, Fujioka M, Inoue S, Satomi Y, Nishino H, Tanaka T et al (2003) Genetic analysis of steroid-induced osteonecrosis of the femoral head. J Orthop Sci 8:329–333PubMedCrossRef

73.

Wang XY, Niu XH, Chen WH, Lin N, Song JN, Chen B, Jin H (2008) Effects of apolipoprotein A1 and B gene polymorphism on avascular necrosis of the femoral head in Chinese population. Zhongguo Gu Shang 21:99–102PubMed

74.

Asano T, Takahashi KA, Fujioka M, Inoue S, Ueshima K, Hirata T, Okamoto M et al (2004) Relationship between postrenal transplant osteonecrosis of the femoral head and gene polymorphisms related to the coagulation and fibrinolytic systems in Japanese subjects. Transplantation 77:220–225PubMedCrossRef

75.

Kim TH, Hong JM, Shin ES, Kim HJ, Cho YS, Lee JY, Lee SH et al (2009) Polymorphisms in the annexin gene family and the risk of osteonecrosis of the femoral head in the Korean population. Bone 45:125–131PubMedCrossRef

76.

Kim TH, Hong JM, Oh B, Cho YS, Lee JY, Kim HL, Lee JE et al (2008) Association of polymorphisms in the Interleukin 23 receptor gene with osteonecrosis of femoral head in Korean population. Exp Mol Med 40:418–426PubMedCrossRef

77.

Kenzora JE (1983) Ischemic necrosis of femoral head. Part I. Accumulative cell stress: a hypothesis for the etiology of idiopathic osteonecrosis. Instr Course Lect 32:242–252PubMed

78.

Kenzora JE (1985) Treatment of idiopathic osteonecrosis: the current philosophy and rationale. Orthop Clin North Am 16:717–725PubMed

Titel: Current Concepts on the Pathogenesis and Natural History of Steroid-Induced Osteonecrosis
verfasst von: Christian Powell
Christopher Chang
M. Eric Gershwin
Publikationsdatum: 01.08.2011
Verlag: Humana Press Inc
Erschienen in: Clinical Reviews in Allergy & Immunology / Ausgabe 1/2011
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI: https://doi.org/10.1007/s12016-010-8217-z

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Current Concepts on the Pathogenesis and Natural History of Steroid-Induced Osteonecrosis

Abstract

Neu im Fachgebiet HNO

Akuter Schwindel: Wann lohnt sich eine MRT?

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Update HNO

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2011

Identification of European Allergy Patterns to the Allergen Families PR-10, LTP, and Profilin from Rosaceae Fruits

Novel Challenges for the Allergist

Therapeutic Approaches in Hereditary Angioedema

Atopy Risk in Infants and Children in Relation to Early Exposure to Fish, Oily Fish, or Long-Chain Omega-3 Fatty Acids: A Systematic Review

A Meta-analysis of the Association of Exhaled Carbon Monoxide on Asthma and Allergic Rhinitis

Advantages of Multiplex Proteomics in Clinical Immunology

Neu im Fachgebiet HNO

Akuter Schwindel: Wann lohnt sich eine MRT?

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Update HNO